Conclusion There was a large and highly significant reduction in the use of nebulised racemic epinephrine treatment after the introduction of new national guidelines in 2013, both in primary and secondary healthcare.
← all excerpts
Treatment for acute bronchiolitis before and after implementation of new national guidelines: a retrospective observational study from primary and secondary care in Oslo, Norway.
1
—
—